glp 1 info America's Poison Centers The promise and peril of

Keywords: blood pressure, cholesterol, diabete mellitus, glp-1 receptor agonists, obesity Introduction and background Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), especially semaglutide (famously known as Ozempic or Wegovy), have become very popular in recent years for weight loss, even though their initial indication is for the management of the patient with diabetes mellitus

Incorporating microbiome sequencing and metabolomics in future research would provide deeper mechanistic insights

Meanwhile, for people with overweight or obesity, weight loss itself whether through diet, exercise, drugs, or bariatric surgery has consistently been shown to help relieve the symptoms of knee osteoarthritis

Diabetes Care 27(11):26282635

(2025, February 1)

We believe that long-term weight loss is the result of a combination of healthy choices and not quick fixes